MPEP § 2414.06
[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
*****
Where an amendment is made to a granted patent containing a "Sequence Listing XML", the correction must be made by way of an amendment to the "Sequence Listing XML" pursuant to 1.835(b).